MADDISON RICHARDSON: Open Payments
NPI 1457081903 · DUNKIRK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 30 payments from 14 companies in 2025. Trend: 2023 $291 · 2024 $866 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $95 |
| Lilly USA, LLC | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Novo Nordisk Inc | 3 | $59 |
| PFIZER INC. | 3 | $49 |
| Boston Scientific Corporation | 2 | $42 |
| ABBVIE INC. | 2 | $35 |
| Paratek Pharmaceuticals, Inc. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: TRELEGY ELLIPTA, CAPLYTA, JARDIANCE, MOUNJARO, WATCHMAN FLX, NURTEC ODT, NUZYRA, GEMTESA.
Industry payments across NY — which companies pay providers there.
